Topoisomerase 1B as a target against leishmaniasis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2015-02-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/138955751503150312120912PMID 25769969
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycosomal targets for anti-trypanosomatid drug discovery.

  2014cited by this paper
• The human topoisomerase 1B Arg634Ala mutation results in camptothecin resistance and loss of inter-domain motion correlation.

  2013cited by this paper
• Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect.

  2013cited by this paper
• New chemotherapeutic strategies against malaria, leishmaniasis and trypanosomiases.

  2013cited by this paper
• Synthesis of Marine α-Methoxylated Fatty Acid Analogs that Effectively Inhibit the Topoisomerase IB from Leishmania donovani with a Mechanism Different from that of Camptothecin

  2013cited by this paper
• Leishmaniasis: current status of available drugs and new potential drug targets.

  2012cited by this paper
• Leishmania (L.) amazonensis peptidase activities inside the living cells and in their lysates.

  2012cited by this paper
• Leishmaniasis Worldwide and Global Estimates of Its Incidence

  2012cited by this paper
• Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.

  2012cited by this paper
• Interaction between natural compounds and human topoisomerase I

  2012cited by this paper
• First total synthesis of the (±)-2-methoxy-6-heptadecynoic acid and related 2-methoxylated analogs as effective inhibitors of the Leishmania topoisomerase IB enzyme

  2012cited by this paper
• Indotecan (LMP400) and AM13-55: Two Novel Indenoisoquinolines Show Potential for Treating Visceral Leishmaniasis

  2012cited by this paper
• Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use.

  2012cited by this paper
• A pentapeptide signature motif plays a pivotal role in Leishmania DNA topoisomerase IB activity and camptothecin sensitivity.

  2012cited by this paper
• Impact of Leishmania metalloprotease GP63 on macrophage signaling

  2012cited by this paper
• Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

  2012cited by this paper
• Leishmaniasis chemotherapy--challenges and opportunities.

  2011cited by this paper
• Development of Derivatives of 3, 3′-Diindolylmethane as Potent Leishmania donovani Bi-Subunit Topoisomerase IB Poisons

  2011cited by this paper
• Validation of a Leishmania infantum ELISA rapid test for serological diagnosis of Leishmania chagasi in dogs.

  2011cited by this paper
• Transplant tourism and donor-derived parasitic infections.

  2011cited by this paper
• Polyamine metabolism in Leishmania: from arginine to trypanothione

  2011cited by this paper
• Characterization of Leishmania donovani Aquaporins Shows Presence of Subcellular Aquaporins Similar to Tonoplast Intrinsic Proteins of Plants

  2011cited by this paper
• Novel Betulin Derivatives as Antileishmanial Agents with Mode of Action Targeting Type IB DNA Topoisomerase

  2011cited by this paper
• ATP independent type IB topoisomerase of Leishmania donovani is stimulated by ATP: an insight into the functional mechanism

  2010cited by this paper
• Assignment of UV-vis spectrum of (3,3')-diindolylmethane, a Leishmania donovani topoisomerase IB inhibitor and a candidate DNA minor groove binder.

  2010cited by this paper
• Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant

  2009cited by this paper
• Pentavalent Antimonials: New Perspectives for Old Drugs

  2009cited by this paper
• Mutational studies reveal lysine 352 on the large subunit is indispensable for catalytic activity of bi-subunit topoisomerase I from Leishmania donovani.

  2009cited by this paper
• Conjugated eicosapentaenoic acid inhibits human topoisomerase IB with a mechanism different from camptothecin.

  2009cited by this paper
• Amino acids 39-456 of the large subunit and 210-262 of the small subunit constitute the minimal functionally interacting fragments of the unusual heterodimeric topoisomerase IB of Leishmania.

  2008cited by this paper
• Mutational study of the "catalytic tetrad" of DNA topoisomerase IB from the hemoflagellate Leishmania donovani: Role of Asp-353 and Asn-221 in camptothecin resistance.

  2008cited by this paper
• Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations

  2008cited by this paper
• Characterizing the bi-subunit type IB DNA topoisomerase of Leishmania parasites; a novel scenario for drug intervention in trypanosomatids.

  2008cited by this paper
• An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3'-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme.

  2008cited by this paper
• Development of new antileishmanial drugs – current knowledge and future prospects

  2008cited by this paper
• Structural insights on the small subunit of DNA topoisomerase I from the unicellular parasite Leishmania donovani.

  2007cited by this paper
• Advances and perspectives in Leishmania cell based drug-screening procedures.

  2007cited by this paper
• Chemotherapy of leishmaniasis: past, present and future.

  2007cited by this paper
• The large subunit of Leishmania topoisomerase I functions as the ‘molecular steer’ in type IB topoisomerase

  2007cited by this paper
• Leishmania donovani bisubunit topoisomerase I gene fusion leads to an active enzyme with conserved type IB enzyme function

  2007cited by this paper
• Liposomal amphotericin B for the treatment of visceral leishmaniasis.

  2006cited by this paper
• Differential induction of Leishmania donovani bi-subunit topoisomerase I–DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I

  2006cited by this paper
• Metabolic functions of glycosomes in trypanosomatids.

  2006cited by this paper
• Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India

  2006cited by this paper
• Topoisomerase I inhibitors: camptothecins and beyond

  2006cited by this paper
• Metabolic Changes in Glucose Transporter-deficient Leishmania mexicana and Parasite Virulence*

  2006cited by this paper
• The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA.

  2006cited by this paper
• Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase.

  2006cited by this paper
• Preparation of transition-state analogues of sterol 24-methyl transferase as potential anti-parasitics.

  2005cited by this paper
• Treatment of visceral leishmaniasis

  2005cited by this paper
• N-terminal Region of the Large Subunit of Leishmania donovani Bisubunit Topoisomerase I Is Involved in DNA Relaxation and Interaction with the Smaller Subunit*

  2005cited by this paper
• Anti-trypanosomal activities of DNA topoisomerase inhibitors.

  2005cited by this paper
• Leishmaniasis: current situation and new perspectives.

  2004cited by this paper
• Miltefosine Induces Apoptosis-Like Death in Leishmania donovani Promastigotes

  2004cited by this paper
• Dual Action of Antimonial Drugs on Thiol Redox Metabolism in the Human Pathogen Leishmania donovani*

  2004cited by this paper
• The crystal structure of glucose-6-phosphate isomerase from Leishmania mexicana reveals novel active site features.

  2004cited by this paper
• Single Mutation in the Linker Domain Confers Protein Flexibility and Camptothecin Resistance to Human Topoisomerase I*

  2003cited by this paper
• Iron Superoxide Dismutases Targeted to the Glycosomes of Leishmania chagasi Are Important for Survival

  2003cited by this paper
• Antimonial-induced Increase in Intracellular Ca2+ through Non-selective Cation Channels in the Host and the Parasite Is Responsible for Apoptosis of Intracellular Leishmania donovani Amastigotes*

  2003cited by this paper
• A Novel Active DNA Topoisomerase I in Leishmania donovani *

  2003cited by this paper
• Antimonial-Mediated DNA Fragmentation inLeishmania infantum Amastigotes

  2001cited by this paper
• Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.

  2000cited by this paper
• Characterization of a Leishmania donovani gene encoding a protein that closely resembles a type IB topoisomerase

  1999cited by this paper
• Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures.

  1999cited by this paper
• Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA.

  1998cited by this paper
• A model for the mechanism of human topoisomerase I.

  1998cited by this paper
• Targeted disruption of the mouse topoisomerase I gene by camptothecin selection

  1996cited by this paper
• Drug cytotoxicity assay for African trypanosomes and Leishmania species.

  1995cited by this paper
• Antitrypanosomal activity of camptothecin analogs. Structure-activity correlations.

  1995cited by this paper
• A type 1 DNA topoisomerase from the kinetoplast hemoflagellate Leishmania donovani.

  1993cited by this paper
• DNA topoisomerase I is essential in Drosophila melanogaster.

  1993cited by this paper
• DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.

  1989cited by this paper
• Acid protease activity of a major surface membrane glycoprotein (gp63) from Leishmania mexicana promastigotes.

  1988cited by this paper
• Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.

  1988cited by this paper
• Antiprotozoal activity of diospyrin towards Leishmania donovani promastigotes in vitro.

  1987cited by this paper
• Cloning and sequencing of Schizosaccharomyces pombe DNA topoisomerase I gene, and effect of gene disruption.

  1987cited by this paper
• Toxic effects of fatty acids on Leishmania donovani promastigotes.

  1986cited by this paper
• Expression and size heterogeneity of a 63 kilodalton membrane glycoprotein during growth and transformation of Leishmania mexicana amazonensis.

  1986cited by this paper
• The major surface protein of Leishmania promastigotes is a protease.

  1986cited by this paper
• Evidence that the major surface proteins of three Leishmania species are structurally related.

  1985cited by this paper
• Surface antigenic change during differentiation of a parasitic protozoan, Leishmania mexicana: Identification by monoclonal antibodies.

  1982cited by this paper
• Effect of long-chain fatty acids on some trypanosomatid flagellates.

  1972cited by this paper

• TDP1 knockout Leishmania donovani accumulate topoisomerase 1‐linked DNA damage and are hypersensitive to clinically used antileishmanial drugs

  2022cites this paper
• A patent review of topoisomerase I inhibitors (2016–present)

  2021cites this paper
• Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan

  2021cites this paper
• A “Golden Age” for the discovery of new antileishmanial agents: Current status of leishmanicidal gold complexes and prospective targets beyond the trypanothione system

  2021cites this paper
• Synthesis of a novel brominated vinylic fatty acid with antileishmanial activity that effectively inhibits the Leishmania topoisomerase IB enzyme mediated by halogen bond formation

  2019cites this paper
• DNA Topoisomerases of Leishmania parasites; druggable targets for drug discovery.

  2019cites this paper
• Imidazo[2,1-a]isoindole scaffold as an uncharted structure active on Leishmania donovani.

  2019cites this paper
• Evaluation of ATM Kinase Inhibitor KU-55933 as Potential Anti-Toxoplasma gondii Agent

  2019cites this paper
• Efficacy of a Binuclear Cyclopalladated Compound Therapy for Cutaneous Leishmaniasis in the Murine Model of Infection with Leishmania amazonensis and Its Inhibitory Effect on Topoisomerase 1B

  2017cites this paper
• Nuclear DNA replication and repair in parasites of the genus Leishmania: Exploiting differences to develop innovative therapeutic approaches

  2017cites this paper
• Human Topoisomerase I Inhibitors

  2016cites this paper
• Antiparasitic effect of Dinoponera quadriceps giant ant venom.

  2016cites this paper
• Drug target identification in protozoan parasites

  2016cites this paper
• Antileishmanial effect of new indeno-1,5-naphthyridines, selective inhibitors of Leishmania infantum type IB DNA topoisomerase.

  2016cites this paper